Research map: The XX Factor in Hemophilia: Diagnostic, Therapeutic, and Research Gaps for Women and Girls

Back to the article

Papers in this map

  1. WFH Guidelines for the Management of Hemophilia, 3rd edition · Alok Srivastava · 2020 · 2035 citations · Cited by this paper
  2. Real‐World Outcomes of Prophylaxis With rIX‐FP in Germany: A Prospective, Non‐Interventional Study in Haemophilia B · 2026 · Related
  3. Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies · Michael U. Callaghan · 2020 · 304 citations · Cited by this paper
  4. Gait Pattern at Different Speeds in Persons With Haemophilia · 2026 · Related
  5. Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A · Annette von Drygalski · 2023 · 204 citations · Cited by this paper
  6. Accuracy of Factor VIII Assays for Measuring Damoctocog Alfa Pegol: A Comparative Analysis · 2026 · Related
  7. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH · Karin P. M. van Galen · 2021 · 169 citations · Cited by this paper
  8. Real‐World Effectiveness and Safety of Concizumab Prophylaxis in Hemophilia: Results From a National French Cohort · 2026 · Related
  9. Real‐world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures · Isabella McCary · 2020 · 112 citations · Cited by this paper
  10. Seventh Åland Island Meeting on von Willebrand Disease · 2026 · Related
  11. Sexism in the management of bleeding disorders · Angela C. Weyand · 2020 · 102 citations · Cited by this paper
  12. The Analysis of the FIX‐inhibitor Risks Associated With the F9 Genotype in Patients With Haemophilia B Exposes the Involvement of Nonsense Mediated‐decay: Argentinean and International Series · 2026 · Related
  13. Genetic causes of haemophilia in women and girls · Connie H. Miller · 2020 · 75 citations · Cited by this paper
  14. Predictors and Clinical Impact of Time to Diagnosis in Acquired Haemophilia A: An 11‐Year Retrospective Cohort Study · 2026 · Related
  15. Women and girls with haemophilia: Lessons learned · Roseline d’Oiron · 2020 · 63 citations · Cited by this paper
  16. Successful Treatment of Heavy Menstrual Bleeding in a Woman With Mild Haemophilia A Using Efanesoctocog Alfa · 2026 · Related
  17. Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial · Andrew D. Leavitt · 2024 · 47 citations · Cited by this paper
  18. Weight‐Bearing Lunge Test in Young Patients With Haemophilia and Limited Joint Damage: Reliability and Functional Associations for Ankle Assessment · 2026 · Related
  19. Phenotype–genotype correlations in hemophilia A carriers are consistent with the binary role of the phase between F8 and X‐chromosome inactivation · Claudia Pamela Radic · 2015 · 40 citations · Cited by this paper
  20. Real‐World Unmet Treatment Needs for Patients With Haemophilia: Results From the Global Adelphi Disease Specific Programme Database · 2026 · Related
  21. The lived experience of women with a bleeding disorder: A systematic review · Anna Sanigorska · 2022 · 40 citations · Cited by this paper
  22. Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues · Angela C. Weyand · 2022 · 38 citations · Cited by this paper
  23. Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial · Davide Matino · 2025 · 38 citations · Cited by this paper
  24. Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review · Ateefa Chaudhury · 2020 · 34 citations · Cited by this paper
  25. Joint comorbidities among Swedish carriers of haemophilia: A register‐based cohort study over 22 years · Mehdi Osooli · 2019 · 30 citations · Cited by this paper
  26. Factor-mimetic and rebalancing therapies in hemophilia A and B: the end of factor concentrates? · Patrick Ellsworth · 2021 · 29 citations · Cited by this paper
  27. Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B · Steven W. Pipe · 2025 · 21 citations · Cited by this paper
  28. Women and girls with inherited bleeding disorders: Focus on haemophilia carriers and heavy menstrual bleeding · Cedric R.J.R. Hermans · 2024 · 20 citations · Cited by this paper
  29. Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial · Davide Matino · 2025 · 12 citations · Cited by this paper
  30. Discrepancy between one-stage clotting and chromogenic factor VIII activity in women with hemophilia A and hemophilia A carriers: a retrospective clinical study · Stéphanie Desage · 2025 · 11 citations · Cited by this paper
  31. Proactive systematic hemophilia carrier screening: a step toward gender equity in hemophilia care · Evelien Krumb · 2024 · 10 citations · Cited by this paper
  32. Women and girls’ participation in haemophilia clinical trials · Stacey A. Fedewa · 2024 · 9 citations · Cited by this paper
  33. Factor activity levels and bleeding scores in pediatric hemophilia carriers enrolled in the ATHNdataset · John Puetz · 2023 · 7 citations · Cited by this paper
  34. Are Women Welcome in Haemophilia Trials? · Meaghan Louise O'Donnell · 2025 · 7 citations · Cited by this paper
  35. Assessment of joint health in females with haemophilia: The carriers ultrasound project (CUP) study · Fernando F. Corrales‐Medina · 2024 · 6 citations · Cited by this paper
  36. Concizumab prophylaxis in people with hemophilia A or B without inhibitors: patient-reported outcome results from the phase 3 explorer8 study · Pantep Angchaisuksiri · 2025 · 6 citations · Cited by this paper
  37. Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis · Cedric R.J.R. Hermans · 2023 · 5 citations · Cited by this paper
  38. Concizumab in hemophilia with inhibitors: longer-term efficacy and safety results from the phase 3 explorer7 study · Johnny Ndoni Mahlangu · 2026 · 5 citations · Cited by this paper
  39. Factor activity levels and bleeding scores in hemophilia carriers: apparent paradoxes · John Puetz · 2025 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)